Hillsdale Investment Management Inc. Grows Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Hillsdale Investment Management Inc. grew its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 80.6% in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 280 shares of the medical equipment provider’s stock after purchasing an additional 125 shares during the quarter. Hillsdale Investment Management Inc.’s holdings in Intuitive Surgical were worth $94,000 at the end of the most recent quarter.

A number of other institutional investors have also recently made changes to their positions in the stock. Baystate Wealth Management LLC lifted its position in shares of Intuitive Surgical by 150.0% in the 4th quarter. Baystate Wealth Management LLC now owns 75 shares of the medical equipment provider’s stock worth $25,000 after purchasing an additional 45 shares during the period. MCF Advisors LLC raised its position in shares of Intuitive Surgical by 108.1% in the 4th quarter. MCF Advisors LLC now owns 77 shares of the medical equipment provider’s stock worth $26,000 after acquiring an additional 40 shares in the last quarter. Atticus Wealth Management LLC raised its position in shares of Intuitive Surgical by 85.4% in the 4th quarter. Atticus Wealth Management LLC now owns 89 shares of the medical equipment provider’s stock worth $30,000 after acquiring an additional 41 shares in the last quarter. MeadowBrook Investment Advisors LLC bought a new position in shares of Intuitive Surgical in the 4th quarter worth approximately $30,000. Finally, Headinvest LLC bought a new position in shares of Intuitive Surgical in the 3rd quarter worth approximately $28,000. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Analysts Set New Price Targets

Several research analysts have recently issued reports on the company. Jefferies Financial Group increased their target price on Intuitive Surgical from $365.00 to $375.00 and gave the stock a “hold” rating in a research report on Friday, April 19th. Royal Bank of Canada upped their price target on Intuitive Surgical from $400.00 to $432.00 and gave the stock an “outperform” rating in a research note on Wednesday, January 24th. Barclays raised their price objective on Intuitive Surgical from $385.00 to $430.00 and gave the company an “overweight” rating in a research report on Thursday, January 25th. Citigroup raised their price objective on Intuitive Surgical from $428.00 to $462.00 and gave the company a “buy” rating in a research report on Wednesday, April 3rd. Finally, StockNews.com lowered Intuitive Surgical from a “buy” rating to a “hold” rating in a research report on Thursday, February 29th. Five research analysts have rated the stock with a hold rating and thirteen have given a buy rating to the stock. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average target price of $396.17.

Intuitive Surgical Trading Up 0.5 %

Intuitive Surgical stock opened at $402.11 on Wednesday. The firm has a market cap of $142.63 billion, a price-to-earnings ratio of 72.58, a PEG ratio of 5.17 and a beta of 1.39. The stock has a fifty day simple moving average of $385.64 and a two-hundred day simple moving average of $360.64. Intuitive Surgical, Inc. has a 12 month low of $254.85 and a 12 month high of $403.76.

Intuitive Surgical (NASDAQ:ISRG) last released its quarterly earnings results on Thursday, April 18th. The medical equipment provider reported $1.50 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.40 by $0.10. The firm had revenue of $1.89 billion for the quarter, compared to the consensus estimate of $1.87 billion. Intuitive Surgical had a return on equity of 12.91% and a net margin of 27.16%. The company’s revenue for the quarter was up 11.5% on a year-over-year basis. During the same period last year, the business posted $1.00 EPS. On average, equities research analysts forecast that Intuitive Surgical, Inc. will post 4.8 EPS for the current fiscal year.

Insider Transactions at Intuitive Surgical

In other news, SVP Mark Brosius sold 175 shares of the firm’s stock in a transaction on Wednesday, May 15th. The stock was sold at an average price of $387.22, for a total value of $67,763.50. Following the transaction, the senior vice president now directly owns 533 shares in the company, valued at approximately $206,388.26. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. In related news, EVP Robert Desantis sold 20,296 shares of Intuitive Surgical stock in a transaction on Friday, March 8th. The stock was sold at an average price of $393.80, for a total transaction of $7,992,564.80. Following the transaction, the executive vice president now directly owns 5,507 shares in the company, valued at $2,168,656.60. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, SVP Mark Brosius sold 175 shares of Intuitive Surgical stock in a transaction on Wednesday, May 15th. The shares were sold at an average price of $387.22, for a total value of $67,763.50. Following the transaction, the senior vice president now owns 533 shares in the company, valued at $206,388.26. The disclosure for this sale can be found here. Insiders have sold a total of 148,290 shares of company stock worth $57,207,154 in the last ninety days. Insiders own 0.80% of the company’s stock.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.